Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin

Cardio-Oncology(2021)10.1186/s40959-021-00103-0Source: DataRank Database

CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin is a research paper published in Cardio-Oncology (2021). On theSindex it has a DataRank of 0.406. It has been cited 14 times.

N/A

0.406DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: goldTopics (15)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.406

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (9)

Badri Karthikeyan ORCID,Adolfo Quiñones‐Lombraña ORCID,Rachael Hageman Blair ORCID,Amy Early,Ellis Levine ORCID

Live enrichment

PubMed:33975650 PMC:PMC8111996

National Institutes of Health

Grant: GM073646

National Institutes of Health

Grant: K08HL130594

National Institutes of Health

Grant: K08HL131987

National Center for Advancing Translational Sciences

Grant: UL1R001412

U.S. Department of Veterans Affairs

Grant: IK2BX004097

NCATS NIH HHS

Grant: KL2 TR001413

National Institutes of Health

Grant: 1K08HL130594-01A1

The Functional Role of Exosomes in Stem Cell-Mediated Cardiac Repair

National Institutes of Health

Grant: 5K08HL131987-02

Galectin-3-Mediated Post-Ischemic Myocardial Dysfunction and its Inhibition by a Novel Peptide N-Acetyl-Seryl-Aspartyl-Lysyl-Proline

National Institutes of Health

Grant: 1R01GM073646-01

PHARMACOGENETICS OF HUMAN CARBONYL REDUCTASES

National Institutes of Health

Grant: 5IK2BX004097-05

The Functional Role of Exosomes in Stem Cell Mediated Cardiac Repair

goldLicense: cc-by

publisherhttps://cardiooncologyjournal.biomedcentral.com/track/pdf/10.1186/s40959-021-00103-0

publisherhttps://link.springer.com/content/pdf/10.1186/s40959-021-00103-0.pdf

publisherhttps://link.springer.com/article/10.1186/s40959-021-00103-0/fulltext.html

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8111996

repositoryhttps://doaj.org/article/89fad400f0164475859f191de1cdfeae

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

Breast cancerChemotherapyCardiovascular diseaseCardiotoxicitydoxorubicinAnthracyclinesurvivorshipCarbonyl Reductase 3ResearchNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC666-701Diseases of the circulatory (Cardiovascular) systemRC254-282

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin

10.6084/m9.figshare.14576598.v1figshare

Additional file 1 of CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin

10.6084/m9.figshare.14576598figshare

CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin

10.6084/m9.figshare.c.5421006figshare

CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin

10.6084/m9.figshare.c.5421006.v1figshare

CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin

FAIR Checklist

DataRank Breakdown

Authors (9)

Funding (10 grants)

Open Access

Topics

Linked Datasets (4)

Annotations (Europe PMC)